Steven Rasmussen

Q: What Schools Are Affiliated With Steven Rasmussen

Steven Rasmussen is affiliated with the following schools: Harvard University, Brown University, Stanford University

Steven Rasmussen's AcademicInfluence.com Rankings

Steven Rasmussen

Biology

#9362

World Rank

#12559

Historical Rank

biology Degrees

Download Badge

Biology

Steven Rasmussen's Degrees

Doctorate Medicine Harvard University
PhD Psychiatry Stanford University

Why Is Steven Rasmussen Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Steven Rasmussen is an American psychiatrist, currently the Mary E. Zucker Professor of Psychiatry and Human Behavior at Brown University, and is a major figure in his field. He is a member of the Society for Neuroscience and American Psychological Association.

(See a Problem?)

Steven Rasmussen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. (1989) (6725)
The Yale-Brown Obsessive Compulsive Scale. II. Validity. (1989) (2580)
The epidemiology and clinical features of obsessive compulsive disorder. (1992) (837)
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression (2009) (759)
Symptoms of obsessive-compulsive disorder. (1997) (744)
A family study of obsessive-compulsive disorder. (1995) (719)
Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience (2010) (681)
Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. (1986) (608)
A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. (1997) (571)
The Brown Assessment of Beliefs Scale: reliability and validity. (1998) (536)
DSM-IV field trial: obsessive-compulsive disorder. (1995) (534)
Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder (2006) (515)
The epidemiology and differential diagnosis of obsessive compulsive disorder. (1992) (462)
Epidemiology of obsessive compulsive disorder. (1984) (456)
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. (1989) (354)
Impact of obsessive-compulsive disorder on quality of life. (2006) (349)
The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. (2006) (308)
Deep Brain Stimulation for Intractable Obsessive Compulsive Disorder: Pilot Study Using a Blinded, Staggered-Onset Design (2010) (301)
Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. (1991) (294)
Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis (2018) (294)
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. (1990) (293)
Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. (2003) (275)
Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. (2002) (265)
Tic-related vs. non-tic-related obsessive compulsive disorder. (1994) (258)
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. (2002) (245)
A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. (2006) (244)
Genome-Wide Association Study in Obsessive-Compulsive Disorder: Results from the OCGAS (2014) (244)
Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. (1988) (235)
Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. (1999) (233)
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. (1995) (225)
Is obsessive–compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective (2011) (224)
Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder (2006) (223)
Hoarding in obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. (2007) (205)
Obsessive compulsive disorder with psychotic features. (1993) (198)
Insight in obsessive compulsive disorder and body dysmorphic disorder. (2004) (186)
Yale-Brown Obsessive Compulsive Scale (Y-BOCS) (1991) (186)
Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. (1999) (185)
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. (2006) (180)
Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study (2009) (179)
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. (2009) (176)
Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. (1997) (169)
Five-year course of obsessive-compulsive disorder: predictors of remission and relapse. (2013) (168)
Rules Ventral Prefrontal Cortical Axons Use to Reach Their Targets: Implications for Diffusion Tensor Imaging Tractography and Deep Brain Stimulation for Psychiatric Illness (2011) (165)
Familiality of Factor Analysis-Derived YBOCS Dimensions in OCD-Affected Sibling Pairs from the OCD Collaborative Genetics Study (2007) (163)
Predictors of course in obsessive compulsive disorder (1999) (159)
Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. (2010) (159)
Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. (2007) (158)
Moclobemide in social phobia: a controlled dose-response trial. (1997) (153)
Yale Brown Obsessive Compulsive Scale (2017) (151)
Levels of family assessment: I. Family, marital, and parent–child interaction. (1998) (150)
Clinical Features and Phenomenology of Obsessive Compulsive Disorder (1989) (150)
Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. (2006) (149)
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. (1990) (148)
Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q (2006) (145)
Treatment strategies for chronic and refractory obsessive-compulsive disorder. (1997) (141)
Insight and treatment outcome in obsessive-compulsive disorder. (2001) (139)
Further development of YBOCS dimensions in the OCD Collaborative Genetics Study: Symptoms vs. categories (2008) (138)
Levels of family assessment: II. Impact of maternal psychopathology on family functioning. (1998) (128)
Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial. (2014) (126)
Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. (1988) (125)
Obsessive–compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders (2007) (124)
A 1 year double‐blind placebo‐controlled fixed dose study of sertraline in the treatment of obsessive‐compulsive disorder (1995) (123)
Mirtazapine Augmentation in the Treatment of Refractory Depression (1999) (121)
A 2-year prospective follow-up study of the course of obsessive-compulsive disorder. (2010) (121)
Parental psychopathology, multiple contextual risks, and one-year outcomes in children. (1996) (121)
Refractory obsessive-compulsive disorder: state-of-the-art treatment. (2002) (117)
Treatment of resistant obsessive-compulsive disorder with ventral capsular/ventral striatal gamma capsulotomy: a pilot prospective study. (2009) (117)
Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. (1994) (115)
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. (2001) (113)
A family‐based association study of the glutamate transporter gene SLC1A1 in obsessive–compulsive disorder in 378 families (2009) (110)
What's in a “Smile?” Intra-operative Observations of Contralateral Smiles Induced by Deep Brain Stimulation (2004) (109)
Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. (1996) (105)
Treatment of severe obsessive-compulsive disorder with fluvoxamine. (1987) (105)
OCD with comorbid OCPD: a subtype of OCD? (2008) (101)
Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. (2008) (99)
The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement. (2006) (97)
Topographic evoked potential mapping in obsessive-compulsive disorder: Evidence of frontal lobe dysfunction (1989) (90)
Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder. (1984) (87)
Obsessive–compulsive disorder: subclassification based on co-morbidity (2008) (86)
Meta‐analysis of association between obsessive‐compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1 (2013) (86)
Comprehensive family‐based association study of the glutamate transporter gene SLC1A1 in obsessive‐compulsive disorder (2011) (83)
Current issues in the pharmacologic management of obsessive compulsive disorder. (1993) (82)
Impulse control disorders in adults with obsessive compulsive disorder. (2006) (81)
Taboo thoughts and doubt/checking: A refinement of the factor structure for obsessive–compulsive disorder symptoms (2007) (80)
The OCD collaborative genetics study: Methods and sample description (2006) (78)
Sexual obsessions and clinical correlates in adults with obsessive-compulsive disorder. (2006) (78)
Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder. (2008) (77)
Clarifying the convergence between obsessive compulsive personality disorder criteria and obsessive compulsive disorder. (2006) (75)
A Pilot Study of Moderate-Intensity Aerobic Exercise for Obsessive Compulsive Disorder (2007) (73)
Clinical features of obsessive-compulsive disorder. (2000) (72)
Patient utilization of cognitive-behavioral therapy for OCD. (2011) (71)
Obsessive compulsive personality disorder and obsessive compulsive disorder: clinical characteristics, diagnostic difficulties, and treatment. (2005) (69)
Behavioural and physiological effects of electrical stimulation in the nucleus accumbens: a review. (2007) (64)
Gamma Ventral Capsulotomy in Intractable Obsessive-Compulsive Disorder (2017) (64)
Association of SLC6A4 variants with obsessive-compulsive disorder in a large multi-center US family study (2009) (64)
Substance use disorders in an obsessive compulsive disorder clinical sample. (2009) (64)
A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder. (2012) (63)
A 2‐year study of sertraline in the treatment of obsessive‐compulsive disorder (1997) (62)
Long-term course of pediatric obsessive-compulsive disorder: 3 years of prospective follow-up. (2014) (61)
A time-limited behavioral group for treatment of obsessive-compulsive disorder. (1998) (57)
The epidemiology of obsessive compulsive disorder. (1984) (54)
Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation. (2000) (52)
A screen of SLC1A1 for OCD‐related alleles (2010) (48)
Prediction of remission in obsessive compulsive disorder using a novel machine learning strategy (2015) (48)
Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder (2017) (48)
Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. (1990) (48)
Can Transcranial Direct Current Stimulation Augment Extinction of Conditioned Fear? (2016) (47)
Who qualifies for deep brain stimulation for OCD? Data from a naturalistic clinical sample. (2014) (47)
Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder. (1988) (46)
Late-onset obsessive compulsive disorder: Clinical characteristics and psychiatric comorbidity (2007) (44)
Polygenic risk score and heritability estimates reveals a genetic relationship between ASD and OCD (2017) (43)
Extinction retention and fear renewal in a lifetime obsessive–compulsive disorder sample (2015) (42)
Sex-specific clinical correlates of hoarding in obsessive-compulsive disorder. (2008) (42)
A comparison of quality of life and psychosocial functioning in obsessive-compulsive disorder and body dysmorphic disorder. (2007) (42)
Whole genome association analysis of treatment response in obsessive-compulsive disorder (2015) (42)
Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive‐compulsive disorder with compulsive hoarding (2008) (40)
Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist. (2010) (38)
Genetic studies of obsessive-compulsive disorder. (1993) (38)
An Avoidance-Based Rodent Model of Exposure With Response Prevention Therapy for Obsessive-Compulsive Disorder (2016) (37)
Hoarding in Children and Adolescents with Obsessive-Compulsive Disorder. (2014) (36)
The use of antibody D8/17 to identify B cells in adults with obsessive–compulsive disorder (2001) (36)
Demographic and clinical characteristics associated with treatment status in family members with obsessive‐compulsive disorder (2008) (34)
Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. (2004) (33)
The role of avoidance in the phenomenology of obsessive-compulsive disorder. (2012) (31)
Clinical features of obsessive-compulsive disorder in elderly patients. (1997) (31)
Obsessive-compulsive disorder in dermatologic practice. (1985) (30)
Obsessive compulsive spectrum disorders. (1994) (30)
Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder (2013) (30)
Gender differences in genetic linkage and association on 11p15 in obsessive–compulsive disorder families (2009) (30)
Neuropsychological Outcome after Deep Brain Stimulation in the Ventral Capsule/Ventral Striatum for Highly Refractory Obsessive-Compulsive Disorder or Major Depression (2013) (29)
Parental bonding and hoarding in obsessive-compulsive disorder. (2017) (28)
Stop Signal Reaction Time Deficits in a Lifetime Obsessive-Compulsive Disorder Sample (2016) (28)
Obsessions and Delusions: The Relationship Between Obsessive-Compulsive Disorder and the Psychotic Disorders (1999) (27)
Coexisting obsessive compulsive disorder and alcoholism. (1989) (27)
An investigation of doubt in obsessive-compulsive disorder. (2017) (27)
Impulse-control disorders in children and adolescents with obsessive-compulsive disorder (2010) (27)
Treatment of Resistant Obsessive-Compulsive Disorder With Ventral Capsular/Ventral Striatal Gamma Capsulotomy: A Pilot Prospective Study (2009) (27)
Should the DSM diagnostic groupings be changed (2003) (26)
Rare Synaptogenesis-Impairing Mutations in SLITRK5 Are Associated with Obsessive Compulsive Disorder (2017) (26)
Transcranial Direct Current Stimulation (tDCS) Targeting Left Dorsolateral Prefrontal Cortex Modulates Task-Induced Acute Pain in Healthy Volunteers. (2015) (26)
Dr. Eisen and Colleagues Reply (1997) (25)
Separation anxiety disorder in OCD (2011) (24)
Development of the Treatment Adherence Survey-patient version (TAS-P) for OCD. (2008) (24)
Design and Rationale for a Randomized Controlled Trial Testing the Efficacy of Aerobic Exercise for Patients with Obsessive-Compulsive Disorder. (2012) (24)
Erratum: Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder (Neuropsychopharmacology (2006) 31, (2384-2393) DOI: 10.1038/sj.npp.1301165 (2006) (24)
A pilot randomized controlled trial of aerobic exercise as an adjunct to OCD treatment. (2017) (23)
OBSESSIVE–COMPULSIVE PERSONALITY DISORDER: EVIDENCE FOR TWO DIMENSIONS (2016) (23)
Symptom subtype and quality of life in obsessive-compulsive disorder (2017) (23)
An empirical investigation of incompleteness in a large clinical sample of obsessive compulsive disorder. (2016) (21)
Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition. (2019) (21)
Parental Accommodation Predicts Symptom Severity at Long-Term Follow-Up in Children with Obsessive–Compulsive Disorder: A Preliminary Investigation (2016) (20)
Deep Brain Stimulation for Psychiatric Disorders. (2002) (20)
Effect of microtubular antagonists on lymphocyte mitogenesis (1977) (20)
Prevalence and clinical characteristics of mental rituals in a longitudinal clinical sample of obsessive–compulsive disorder (2011) (19)
Functional Disruption of Cerebello-thalamo-cortical Networks in Obsessive-Compulsive Disorder. (2019) (19)
ADHD and executive functioning deficits in OCD youths who hoard. (2016) (19)
Effects of yohimbine in obsessive compulsive disorder (2004) (18)
Homeobox genes in obsessive‐compulsive disorder (2012) (18)
Neurosurgical Approaches to Intractable Obsessive-Compulsive Disorder (2000) (17)
Toward a Neuroanatomy of Obsessive-Compulsive Disorder Revisited (2013) (17)
Neuropsychological Outcome of Ventral Capsular/Ventral Striatal Gamma Capsulotomy for Refractory Obsessive-Compulsive Disorder: A Pilot Study (2009) (17)
OCD behavior therapy before and after gamma ventral capsulotomy: Case report (2014) (17)
The impact of lifetime PTSD on the seven-year course and clinical characteristics of OCD (2017) (17)
Epidemiologic and clinical findings of significance to the design of neuropharmacologic studies of obsessive-compulsive disorder. (1986) (16)
Directionality of change in obsessive compulsive disorder (OCD) and suicidal ideation over six years in a naturalistic clinical sample✰. (2019) (16)
Genome Wide Association Study (GWAS) between Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD) (2017) (16)
Reduced focal fiber collinearity in the cingulum bundle in adults with obsessive-compulsive disorder (2019) (15)
Functional disruption in prefrontal-striatal network in obsessive-compulsive disorder (2020) (14)
Vagus nerve stimulation and deep brain stimulation for treatment resistant depression. (2006) (14)
Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder (2019) (14)
A cross-cultural clinical comparison between subjects with obsessive-compulsive disorder from the United States and Brazil (2017) (12)
Effects of Transcranial Direct Current Stimulation (tDCS) on Pain Distress Tolerance: A Preliminary Study. (2015) (12)
Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder. (2014) (12)
Self-reported executive function and hoarding in adults with obsessive-compulsive disorder. (2018) (12)
15 – Obsessive-Compulsive Personality Disorder (2017) (11)
Longitudinal course of body-focused repetitive behaviors in obsessive-compulsive disorder. (2015) (10)
Using individual items to clarify OCD symptom structure: the case for five factors. (2009) (10)
Longitudinal course of pharmacotherapy in obsessive–compulsive disorder (2013) (10)
Erratum: DSM-IV field trial: Obsessive-compulsive disorder (American Journal of Psychiatry (January 1995) (90-96)) (1995) (10)
Trichotillomania comorbidity in a sample enriched for familial obsessive-compulsive disorder. (2019) (9)
Yale-Brown Obsessive-Compulsive Scale–Second Edition (2011) (9)
Fluvoxamine as an antiobsessional agent. (1989) (8)
Clinical correlates and genetic linkage of social and communication difficulties in families with obsessive–compulsive disorder: Results from the OCD Collaborative Genetics Study (2014) (8)
Personality measures after gamma ventral capsulotomy in intractable OCD (2018) (8)
Treatment-resistant mood disorders: Drug combination strategies (2001) (8)
Predicting course of illness in patients with severe obsessive-compulsive disorder. (2015) (8)
Magnetic Resonance Imaging-Guided Laser Thermal Ventral Capsulotomy for Intractable Obsessive-Compulsive Disorder. (2021) (8)
Yale Brown Obsessive Compulsive Scale--Modified for Body Dysmorphic Disorder (2017) (8)
Obsessive-compulsive disorder: recognition across medical settings, and treatments from behavior therapy to neurosurgery. (2006) (7)
Behavioral therapy teams for adults with OCD in a community mental health center: An open trial (2017) (7)
Genome-wide association study identifies new locus associated with OCD (2021) (7)
Long-term Course of Pediatric Obsessive-Compulsive Disorder: Three Years of Prospective Follow-up (2015) (7)
The natural history of obsessive-compulsive disorder. (1999) (7)
Risk judgment in Obsessive–Compulsive Disorder: Testing a dual-systems account (2013) (7)
Neural mechanisms of persistent avoidance in OCD: A novel avoidance devaluation study (2020) (6)
Dependent personality, separation anxiety disorder and other anxiety disorders in OCD. (2016) (6)
Treating imagined ugliness. (1999) (6)
The Meta-analytic Saga of Serotonin Reuptake Inhibitors in an Obsessional World (1996) (5)
Drs. Rasmussen and Tsuang Reply (1987) (5)
Neuropsychological outcome of ventral capsular/ventral striatal gamma capsulotomy for refractory obsessive-compulsive disorder: a pilot study. (2009) (5)
Prolonged avoidance training exacerbates OCD-like behaviors in a rodent model (2020) (5)
Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Act (2021) (5)
Behavioral Therapy Teams for Obsessive-Compulsive Disorder: Lessons Learned From a Pilot Randomized Trial in a Community Mental Health Center. (2021) (4)
P-6-9 Double-blind comparison of fluvoxamine and clomipramine in obsessive compulsive disorder in the United States (1995) (4)
P-6-14 Long-term sertraline treatment of obsessive compulsive disorder: A 2 year study (1995) (4)
Stress and Depression: Is Neuroimmunology the Missing Link? (1997) (4)
Brown Assessment of Beliefs Scale (2017) (4)
111 THE COURSE AND CLINICAL FEATURES OF OBSESSIVE-COMPULSIVE DISORDER (2002) (3)
The prefrontal cortex and neurosurgical treatment for intractable OCD (2021) (3)
The Brown Incompleteness Scale (BINCS): Measure development and initial evaluation. (2018) (3)
Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design (2021) (3)
Long-term sertraline treatment of obsessive compulsive disorder: a 52-week double-blind comparative study versus placebo (1992) (3)
Parental Accommodation Predicts Symptom Severity at Long-Term Follow-Up in Children with Obsessive–Compulsive Disorder: A Preliminary Investigation (2016) (2)
General personality dimensions, impairment and treatment response in obsessive-compulsive disorder. (2019) (2)
Differential Parental Influence in the Familial Aggregation of Obsessive Compulsive Disorder. (2014) (2)
Impact of the peripartum period on the longitudinal course of obsessive–compulsive disorder (2021) (2)
Surgery for psychiatric disorders (2003) (2)
140. Effects of Cathodal tDCS Over Pre-SMA on Brain Functional Connectivity in OCD (2018) (1)
Obsessive-Compulsive Disorder in Young Adults (2009) (1)
Children’s Yale-Brown Obsessive-Compulsive Scale Second Edition (2019) (1)
Deep brain stimulation (DBS) for OCD: Effects in multiple domains (2006) (1)
Social functioning and quality of life in obsessive compulsive disorder (2017) (1)
P.2.060 Mirtazapine augmentation in the treatment of refractory depression (2005) (0)
Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder (2017) (0)
Directionality of change in obsessive compulsive disorder and depression over six years of prospective follow-up. (2022) (0)
Neurosurgeries for Intractable OCD: Deep Brain Stimulation and Gamma Ventral Capsulotomy Compared (2019) (0)
207 Stereotactic Radiosurgical Capsulotomy for Obsessive-Compulsive Disorder: Initial Results Using a “Goldilocks” 5-Shot Radiosurgical Plan (2018) (0)
Body Dysmorphic Disorder: Does Prozac Help?: (323852004-007) (2013) (0)
GammaVentral Capsulotomy for Obsessive-Compulsive Disorder A Randomized Clinical Trial (2015) (0)
The epidemiology and differential diagnosis of obsessive compulsive disorder. (1992) (0)
F22. Understanding the Patient Experience of Psychiatric Neurosurgery for Intractable Obsessive Compulsive Disorder (2018) (0)
Heterogeneity and Coexistence in DSM-III-R Obsessive Compulsive Disorder (1989) (0)
Modulating tolerability of acute painful stimuli with transcranial direct current stimulation targeting dorsolateral prefrontal cortex (2015) (0)
Contents Vol. 91, 2013 (2013) (0)
CLINICAL FEATURES OF DISORDER OBSESSIVE-COMPULSIVE (2000) (0)
Enhancing extinction of conditioned fear by transcranial direct current stimulation (2015) (0)
NEUROMODULATION SECTION (2016) (0)
Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods. (2018) (0)
O13. Delayed Treatment and Co-Occurring Psychiatric Illness Predict Response to Gamma Knife Capsulotomy for Obsessive Compulsive Disorder (2018) (0)
Evolutionary and functional data power search for obsessive-compulsive disorder genes (2017) (0)
Update on diagnosis and treatment of obsessive-compulsive disorder (1997) (0)
[What is the role of psychiatric neurosurgery in the 21st Century?]. (2004) (0)
Personality traits as predictors of OCD remission: A longitudinal study. (2022) (0)
Brown Incompleteness Scale (2019) (0)
SIR: The report "Comparison of PET Measurement of Local Brain Glucose Metabolism and CAT Measurement of (1987) (0)
Gamma knife capsulotomy for intractable OCD: Neuroimage analysis of lesion size, location, and clinical response (2023) (0)
The Patient Lived-Experience of Ventral Capsulotomy for Obsessive-Compulsive Disorder: An Interpretive Phenomenological Analysis of Neuroablative Psychiatric Neurosurgery (2022) (0)
Differential assessment of frontally-mediated behaviors between self- and informant-report in patients with obsessive-compulsive disorder following gamma ventral capsulotomy (2022) (0)
Reasons that surgery is used for obsessive-compulsive disorder (2001) (0)

This paper list is powered by the following services:

Other Resources About Steven Rasmussen

en.wikipedia.org

What Schools Are Affiliated With Steven Rasmussen?

Steven Rasmussen is affiliated with the following schools:

Steven Rasmussen's Academic­Influence.com Rankings